| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.33 | 0.05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |